|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Institute on Drug Abuse (NIDA) |
|---|---|
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00033124 |
Purpose
The purpose of this study is to examine behavioral treatment for methamphetamine dependence.
| Condition | Intervention | Phase |
|---|---|---|
|
Substance-Related Disorders |
Behavioral: Behavior Therapy |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | Behavioral Trial for the Treatment of Methamphetamine Dependence |
| Estimated Enrollment: | 50 |
| Study Start Date: | July 2001 |
| Estimated Study Completion Date: | June 2002 |
To characterize meth. withdrawal symptoms using a multidimensional withdrawal questionnaire; to field test and investigate the effect of using an algorithm developed for discriminating between new use and residual carry-over of meth metabolites in urine and to evaluate the treatment response of meth. users to participation in the thrice weekly psychosocial protocol to be used as a "platform" in future pharmacotherapy trials.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Male or Female at least 18 yrs of age; DSM-4 diagnosis of methamphetamine (METH) dependence; be willing to comply with study procedures; verbalize understanding of consent and provide written consent and willingness to complete study procedures; be seeking treatment for METH dependence.
Exclusion Criteria:
Additional criteria available during screening at the site.
Contacts and Locations| United States, California | |
| Matrix Institute on Addictions | |
| Costa Mesa, California, United States, 92627 | |
| South Bay Treatment Center | |
| Chula Vista, California, United States, 91911 | |
| United States, Hawaii | |
| John A. Burns School of Medicine | |
| Honolulu, Hawaii, United States, 96813 | |
| United States, Iowa | |
| Powell Chemical Dependency Center | |
| Des Moines, Iowa, United States, 50316 | |
| United States, Missouri | |
| Comprehensive Mental Health Services, Inc | |
| Independence, Missouri, United States, 64052 | |
| Principal Investigator: | Richard Rawson, Ph.D. | National Institute on Drug Abuse (NIDA) |
More Information
| Study ID Numbers: | NIDA-CTO-0009-1 |
| Study First Received: | April 5, 2002 |
| Last Updated: | February 8, 2007 |
| ClinicalTrials.gov Identifier: | NCT00033124 History of Changes |
| Health Authority: | United States: Federal Government |
|
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Adrenergic Agents Molecular Mechanisms of Pharmacological Action Adrenergic Uptake Inhibitors Sympathomimetics Physiological Effects of Drugs Disorders of Environmental Origin Central Nervous System Stimulants |
Pharmacologic Actions Methamphetamine Mental Disorders Autonomic Agents Therapeutic Uses Substance-Related Disorders Amphetamine Dopamine Agents Peripheral Nervous System Agents Central Nervous System Agents |